Healthcare Triangle, Inc.
HCTI
$0.1449
-$0.0029-1.96%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -64.77% | -55.75% | -47.29% | -38.49% | -27.64% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -64.77% | -55.75% | -47.29% | -38.49% | -27.64% |
| Cost of Revenue | -66.68% | -59.17% | -48.87% | -38.64% | -23.60% |
| Gross Profit | -57.36% | -41.03% | -41.37% | -37.98% | -40.00% |
| SG&A Expenses | -39.18% | -39.67% | -34.81% | -28.50% | -16.04% |
| Depreciation & Amortization | -43.23% | -82.08% | -72.53% | -65.28% | -53.59% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -58.03% | -57.80% | -50.96% | -43.26% | -30.40% |
| Operating Income | 20.62% | 64.74% | 63.88% | 61.51% | 42.54% |
| Income Before Tax | 31.14% | 46.87% | 42.78% | 32.98% | 9.39% |
| Income Tax Expenses | -65.71% | -62.50% | -76.71% | -69.57% | -50.70% |
| Earnings from Continuing Operations | 31.28% | 46.93% | 42.98% | 33.21% | 9.69% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 31.28% | 46.93% | 42.98% | 33.21% | 9.69% |
| EBIT | 20.62% | 64.74% | 63.88% | 61.51% | 42.54% |
| EBITDA | -380.26% | 125.26% | 123.82% | 127.36% | 117.71% |
| EPS Basic | 44.22% | 54.08% | 49.46% | 39.26% | 20.00% |
| Normalized Basic EPS | 29.47% | 71.53% | 66.20% | 58.57% | 42.66% |
| EPS Diluted | 44.22% | 54.08% | 49.46% | 39.26% | 20.00% |
| Normalized Diluted EPS | 29.47% | 71.53% | 66.20% | 58.57% | 42.66% |
| Average Basic Shares Outstanding | 26.37% | 17.29% | 13.54% | 12.08% | 14.95% |
| Average Diluted Shares Outstanding | 26.37% | 17.29% | 13.54% | 12.08% | 14.95% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |